Biovail Names Gilbert Godin Senior Vice-President.TORONTO -- Biovail Corporation (NYSE NYSE See: New York Stock Exchange :BVF BVF Biovail Corporation (stock symbol) BVF Berufsverband der Frauenärzte eV (Muenchen, Germany) BVF Bearing Versus Frequency )(TSX TSX Toronto Stock Exchange (TSE before April, 2002) TSX Transfer from Stack Pointer to Index TSX True Space Extension :BVF) today announced that it has hired Gilbert Godin to become its Senior Vice-President, Technical Operations/Drug Delivery. Mr. Godin, who comes to Biovail from MDS MDS, n See temporomandibular pain-dysfunction syndrome. MDS 1 Maternal deprivation syndrome, see there 2 Myelodysplastic syndrome, see there Pharma Services, will join Biovail May 2. Mr. Godin's responsibilities will focus on the Company's product-development capability, as well as manufacturing and contract-development services. Biovail Chief Executive Officer Dr. Douglas Squires said the addition of Mr. Godin provides Biovail with a unique combination of commercial and scientific expertise. "Gilbert brings a wealth of experience that will enable Biovail to continue to build on its success of providing positive enhancements to medicines," Dr. Squires said. "Our ability to attract a seasoned professional with Mr. Godin's skills and capabilities is indicative of our ability to add depth and experience to the Company." Mr. Godin comes to Biovail from MDS Pharma Services, where, during the past seven years, he held a series of progressively responsible positions in Canada and the United States The United States and Canada share a unique legal relationship. U.S. law looks northward with a mixture of optimism and cooperation, viewing Canada as an integral part of U.S. economic and environmental policy. . Since October 2004, he served as President of MDS Pharma, an organization that provides drug-discovery and development services to pharmaceutical and biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. . His prior appointments at MDS Pharma included Group Vice-President, Early Stage Development; President, Early Clinical Research and Bioanalysis; and Vice-President, Strategic Business Planning and Development. He also served as Vice-President and General Manager, MDS Neo-Pharm. Before joining MDS in 1999, Mr. Godin spent seven years with Schering Plough plough: see plow. , where he held senior positions in France and Canada. He has also held senior positions with L'Oreal Canada and Nabisco Brands. Mr. Godin has a Masters in Business Administration degree from Concordia University in Montreal. He also holds an engineering degree from Sherbrooke University in Quebec. About Biovail Corporation Biovail Corporation is a specialty pharmaceutical company, engaged in the formulation formulation /for·mu·la·tion/ (for?mu-la´shun) the act or product of formulating. American Law Institute Formulation , clinical testing, registration, manufacture, and commercialization of pharmaceutical products utilizing advanced drug-delivery technologies. For more information about Biovail, visit the Company's Web site at www.biovail.com. For further information, please contact Ken Howling at 905-286-3000 or send inquiries to ir@biovail.com. |
|
|||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion